SEATTLE – Investors with losses in Spectrum Pharmaceuticals, Inc. (SPPI) have a limited time to act, as Hagens Berman Sobol Shapiro LLP has announced a 6-day deadline to file a motion to be lead plaintiff in a securities class action lawsuit. The firm is investigating potential violations of federal securities laws on behalf of investors who purchased Spectrum Pharmaceuticals securities between [date not provided in source] and [date not provided in source].
the lawsuit alleges Spectrum Pharmaceuticals made false and misleading statements that artificially inflated the company’s stock price. Investors who experienced losses during the specified period may be eligible to recover their investments. Those wishing to discuss this case and their rights are encouraged to contact Hagens Berman before the lead plaintiff deadline.
Hagens berman is seeking to represent investors in this case and oversee the litigation, protecting the interests of all affected parties. The firm has a proven track record in complex litigation, securing over $2.9 billion for its clients.
Individuals with non-public facts about Spectrum Pharmaceuticals are also encouraged to come forward. Whistleblowers may be eligible for a reward of up to 30 percent of any triumphant recovery obtained by the Securities and Exchange Commission (SEC). Contact Reed Kathrein at 844-916-0895 or [email protected] for more information.
Further details about the case and frequently asked questions are available at hbsslaw.com/cases/spectrum-pharmaceuticals-inc-sppi-securities-class-action.
About Hagens Berman: Hagens Berman is a global plaintiffs’ rights complex litigation firm dedicated to corporate accountability, representing investors, whistleblowers, workers, and consumers. More information can be found at hbsslaw.com and on Twitter @ClassActionLaw.